QDEL - Quidel more quick diagnosis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QDEL - Quidel more quick diagnosis

QDEL 25.37

+4.2%

11:19 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: steve dietrich who wrote (554)	4/5/1997 8:27:00 PM
From: Mike Relyea	of 1693

Welcome back Steve. There's a good article in the 14 April 1997 Business Week that helps explain why Quidel's price is languishing even though it sales and earning are rapidly rising. Quidel's going to be a shining stare in a hot sector when it comes through with more earnings surprises and the small caps rebound: WHERE THE BEAR LURKS Thousands of stocks were ailing before this correction businessweek.com . . . . Small biotech companies, as a group, have declined 28% in the past three months . . . . The full extent of the split between small- and big-cap stocks becomes more apparent when you focus on the NASDAQ. According to the S&P figures, 62% of the 1,100 stocks traded on the NASDAQ small-cap market were flat or down during the past year. The NASDAQ national market system and American Stock Exchange were hit almost as badly: 48% and 45%, respectively. By contrast, only 34% of the New York Stock Exchange's 2,600-odd stocks were flat or losers over the past year. One reason: Institutions stayed in the NYSE and other large-cap issues to avoid risk. But if the big-company indexes stop looking bulletproof, there may be no such haven. In further corrections, the enormous flows that have gone into index funds may go elsewhere, argue Metz and other market analysts. That could help bring back small-cap issues. For value-hunting investors--with strong nerves--their declines may already represent some alluring opportunities. . . . Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next